Shop IDSA Influenza Update for the 2020 – 2021 Flu Season

Influenza Update for the 2020 – 2021 Flu Season

Published: March 2019
$11.95
Print Copy Information:
  • 48 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
Add to Cart
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Key Points
  • Testing and Treatment of Influenza When SARS-CoV-2 and Influenza Viruses are Co-circulating
  • Prevention 
    • Chemoprophylaxis
  • Treatment 
    • Antiviral Dosing
    • Antiviral Treatment for Suspected or Confirmed Influenza
    • Bacterial Coinfection
    • Antiviral Failure
    • Antiviral-resistant Infection Testing
    • Adjunctive Therapy
  • Institutional Outbreak Control
  • Diagnosis
    • Testing
      • Outpatients (including emergency department patients)
      • Hospitalized Patients
    • Specimens
    • Diagnostic Tests* Tables
    • Influenza Vaccines — United States, 2020–21 Influenza Season
    • Contraindications and Precautions to the Use of
  • Influenza Vaccines — United States, 2020–21 Influenza Season
    • Dose Volumes for Inactivated Influenza Vaccines
  • Licensed for Children Aged 6 through 35 months— United States, 2020–21 Influenza Season
    • Antiviral Agents and Dosing Recommendations for
  • Treatment and Chemoprophylaxis of Influenza
    • Control Measures for Managing Institutional Influenza Outbreaks
    • Signs and Symptoms of Uncomplicated Influenza
    • Clinical Manifestations and Complications
  • Associated With Influenza
    • Persons Who Are at High Risk of Complications
  • From Influenza
    • Groups in Whom to Consider a Diagnosis of Influenza
    • Influenza Diagnostic Tests for Respiratory Specimens
    • Multiplex Assays Authorized for Simultaneous Detection of Influenza Viruses and SARS-CoV-2 by FDA Emergency Use Authorization  – List of Differential Diagnoses to Consider for Patients With Influenza Who Do Not Improve or Have Clinical Deterioration With Antiviral Treatment 
  • Figures
    • Influenza Vaccine Dosing Algorithm for Children Aged 6 months through 8 years — Advisory Committee on Immunization Practices, United States, 2020–21 Influenza Season
  • Algorithm
    • Guide for Considering Influenza Testing When Influenza Viruses are Circulating in the Community (regardless of influenza vaccination history)
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

Description

This pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.

You can also find this product included in this bundle!

IDSA Guidelines Bundle

Infectious Diseases Society of America
Last Updated: Oct 24, 2022
$ 352.95 Print Included Guidelines:
  • Acute Hematogenous Osteomyelitis
  • Antibiotic Stewardship
  • Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression
  • Antimicrobial Prophylaxis in Surgery
  • Aspergillosis
  • Asymptomatic Bacteriuria Management
  • Candida
  • Catheter-Associated Bacteriuria
  • Chronic Kidney Disease in HIV-Infected Patients
  • Chronic Pain in HIV
  • Coccidioidomycosis
  • Complicated Intra-abdominal Infection in Adults
  • Cryptococcosis Management
  • Diabetic Foot Infections
  • Diagnosis and Treatment of Adults with Community-Acquired Pneumonia
  • Drug-Susceptible Tuberculosis
  • Fever and Neutropenia in Cancer Patients
  • Guideline on Diagnosis and Management of Babesiosis
  • Hospital-acquired and Ventilator-Associated Pneumonia
  • Infectious Diarrhea
  • Influenza Update for the 2020 - 2021 Flu Season
  • Leishmaniasis
  • Management of Outpatient Parenteral Antimicrobial Therapy
  • Methicillin-Resistant Staphylococcus aureus (MRSA)
  • Native Vertebral Osteomyelitis in Adults
  • Neurocysticercosis
  • Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
  • Pediatric Community-Acquired Pneumonia
  • Prevention, Diagnosis and Treatment of Lyme Disease
  • Primary Care Guidance for Persons with HIV
  • Prosthetic Joint Infection
  • Rhinosinusitis
  • Skin and Soft Tissue Infections
  • Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute-Care Hospitals
  • Streptococcal Pharyngitis Diagnosis and Management
  • Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women
  • Treatment of Drug-Resistant Tuberculosis
  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease
  • Tuberculosis Diagnosis Adults and Children
  • Vaccination of the Immunocompromised Host
  • Ventriculitis and Meningitis Healthcare-Associated
Add to Cart
Need help?